WO2002083727A3 - Nucleic acid sequences of hyperplasies and tumors of the thyroid - Google Patents
Nucleic acid sequences of hyperplasies and tumors of the thyroid Download PDFInfo
- Publication number
- WO2002083727A3 WO2002083727A3 PCT/EP2002/004090 EP0204090W WO02083727A3 WO 2002083727 A3 WO2002083727 A3 WO 2002083727A3 EP 0204090 W EP0204090 W EP 0204090W WO 02083727 A3 WO02083727 A3 WO 02083727A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acid
- hyperplasies
- tumors
- thyroid
- acid sequences
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002310840A AU2002310840A1 (en) | 2001-04-12 | 2002-04-12 | Nucleic acid sequences of hyperplasies and tumors of the thyroid |
JP2002581482A JP2005503123A (en) | 2001-04-12 | 2002-04-12 | Thyroid hyperplasia and tumor nucleic acid sequence |
EP02735249A EP1377607A2 (en) | 2001-04-12 | 2002-04-12 | Nucleic acid sequences of hyperplasies and tumors of the thyroid |
US10/684,042 US20050095594A1 (en) | 2001-04-12 | 2003-10-10 | Nucleic acid sequences of hyperplasies and tumors of the thyroid |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10118452.2 | 2001-04-12 | ||
DE10118452A DE10118452A1 (en) | 2001-04-12 | 2001-04-12 | Nucleic acid sequences from hyperplasias and thyroid tumors |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/684,042 Continuation US20050095594A1 (en) | 2001-04-12 | 2003-10-10 | Nucleic acid sequences of hyperplasies and tumors of the thyroid |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002083727A2 WO2002083727A2 (en) | 2002-10-24 |
WO2002083727A3 true WO2002083727A3 (en) | 2003-04-17 |
Family
ID=7681480
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2002/004090 WO2002083727A2 (en) | 2001-04-12 | 2002-04-12 | Nucleic acid sequences of hyperplasies and tumors of the thyroid |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1377607A2 (en) |
JP (1) | JP2005503123A (en) |
AU (1) | AU2002310840A1 (en) |
DE (1) | DE10118452A1 (en) |
WO (1) | WO2002083727A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005011003B9 (en) * | 2004-03-03 | 2009-02-26 | Universität Leipzig | Method and means for the differential diagnosis of thyroid tumors |
WO2006117217A2 (en) * | 2005-05-04 | 2006-11-09 | Noxxon Pharma Ag | Novel use of spiegelmers |
WO2011023413A1 (en) | 2009-08-31 | 2011-03-03 | Alcedo Biotech Gmbh | Microrna-based methods and compositions for reprogramming cells |
US10404099B1 (en) | 2018-02-28 | 2019-09-03 | Corning Optical Communications LLC | Intermediate power supply unit for distributing lower voltage power to remote power distribution systems |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999033982A2 (en) * | 1997-12-23 | 1999-07-08 | Chiron Corporation | Human genes and gene expression products i |
-
2001
- 2001-04-12 DE DE10118452A patent/DE10118452A1/en not_active Withdrawn
-
2002
- 2002-04-12 WO PCT/EP2002/004090 patent/WO2002083727A2/en active Application Filing
- 2002-04-12 JP JP2002581482A patent/JP2005503123A/en active Pending
- 2002-04-12 EP EP02735249A patent/EP1377607A2/en not_active Ceased
- 2002-04-12 AU AU2002310840A patent/AU2002310840A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999033982A2 (en) * | 1997-12-23 | 1999-07-08 | Chiron Corporation | Human genes and gene expression products i |
Non-Patent Citations (12)
Title |
---|
ANTONINI P ET AL: "CYTOGENETIC ABNORMALITIES IN THYROID ADENOMAS", CANCER GENETICS AND CYTOGENETICS, vol. 52, no. 2, 1991, pages 157 - 164, XP002204612, ISSN: 0165-4608 * |
BELGE G ET AL: "Delineation of a 150-kb breakpoint cluster in benign thyroid tumors with 19q13.4 aberrations.", CYTOGENETICS AND CELL GENETICS, vol. 93, no. 1-2, 2001, pages 48 - 51, XP002204613, ISSN: 0301-0171 * |
BELGE G ET AL: "FISH analyses of a newly established thyroid tumor cell line showing a t(1;19)(p35 or p36:1;q13) reveal that the breakpoint lies between 19q13.3-13.4 and 19q13.4.", CYTOGENETICS AND CELL GENETICS, vol. 69, no. 3-4, 1995, pages 220 - 222, XP002204605, ISSN: 0301-0171 * |
BELGE G. ET AL.: "Zytogenetische Veränderungen bei benignen Schilddrüsenhyperplasien und Adenomen korrelieren mit der Histologie", VERH. DTSCH. GES. PATH., vol. 81, 1997, pages 151 - 156, XP002204607 * |
BELGE GAZANFER ET AL: "Breakpoints of 19q13 translocations of benign thyroid tumors map within a 400 kilobase region.", GENES CHROMOSOMES & CANCER, vol. 20, no. 2, 1997, pages 201 - 203, XP002204604, ISSN: 1045-2257 * |
BELGE GAZANFER ET AL: "Cytogenetic investigations of 340 thyroid hyperplasias and adenomas revealing correlations between cytogenetic findings and histology.", CANCER GENETICS AND CYTOGENETICS, vol. 101, no. 1, February 1998 (1998-02-01), pages 42 - 48, XP002204606, ISSN: 0165-4608 * |
BICHER ANNETTE ET AL: "Loss of heterozygosity in human ovarian cancer on chromosome 19q.", GYNECOLOGIC ONCOLOGY, vol. 66, no. 1, 1997, pages 36 - 40, XP002204610, ISSN: 0090-8258 * |
CLOSS ELLEN I ET AL: "Human cationic amino acid transporters hCAT-1, hCAT-2A, and hCAT-2B: Three related carriers with distinct transport properties.", BIOCHEMISTRY, vol. 36, no. 21, 1997, pages 6462 - 6468, XP002204608, ISSN: 0006-2960 * |
GEORGE M YOUSEF ET AL: "Prostase/KLK-L1 is a new member of the human Kallikrein gene family, is espressed in prostate and breast tissues, and is hormonally regulated", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, vol. 59, no. 17, 1 September 1999 (1999-09-01), pages 4252 - 4256, XP002141958, ISSN: 0008-5472 * |
GUPTA RAJNISH K ET AL: "The t(14:18) chromosomal translocation and Bcl-2 protein expression in Hodgkin's disease.", LEUKEMIA (BASINGSTOKE), vol. 8, no. 8, 1994, pages 1337 - 1341, XP002204611, ISSN: 0887-6924 * |
HOSOKAWA HIROSHI ET AL: "Cloning and characterization of a brain-specific cationic amino acid transporter", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 272, no. 13, 1997, pages 8717 - 8722, XP002193512, ISSN: 0021-9258 * |
WANSCHURA SYLKE ET AL: "Mapping of the translocation breakpoints of primary pleomorphic adenomas and lipomas within a common region of chromosome 12.", CANCER GENETICS AND CYTOGENETICS, vol. 86, no. 1, 1996, pages 39 - 45, XP002204609, ISSN: 0165-4608 * |
Also Published As
Publication number | Publication date |
---|---|
JP2005503123A (en) | 2005-02-03 |
DE10118452A1 (en) | 2002-10-31 |
AU2002310840A1 (en) | 2002-10-28 |
EP1377607A2 (en) | 2004-01-07 |
WO2002083727A2 (en) | 2002-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999057325A3 (en) | Enzymes mixture | |
WO2001075067A8 (en) | Novel nucleic acids and polypeptides | |
WO2001057190A3 (en) | Novel nucleic acids and polypeptides | |
WO2002022660A3 (en) | Novel nucleic acids and polypeptides | |
WO2001066689A3 (en) | Novel nucleic acids and polypeptides | |
WO2002031111A3 (en) | Novel nucleic acids and polypeptides | |
WO2001053455A3 (en) | Novel nucleic acids and polypeptides | |
WO2001088088A3 (en) | Novel nucleic acids and polypeptides | |
WO2002059260A3 (en) | Nucleic acids and polypeptides | |
WO2003025148A3 (en) | Novel nucleic acids and polypeptides | |
WO2002070539A3 (en) | Novel nucleic acids and polypeptides | |
JP2001515920A5 (en) | ||
WO2002028891A3 (en) | Listeria inocua, genome and applications | |
WO2002018424A3 (en) | Nucleic acids and polypeptides | |
EP1209228A3 (en) | Environmental stress responsive promoter | |
WO2001079449A3 (en) | Novel nucleic acids and polypeptides | |
WO2002083727A3 (en) | Nucleic acid sequences of hyperplasies and tumors of the thyroid | |
WO2003035878A3 (en) | Lipase variants | |
EP1167523A3 (en) | Insertion sequence elements derived from ralstonia solanacearum | |
AU2001295456A1 (en) | Nucleotide sequences which code for the gora gene | |
WO2001048185A3 (en) | Transcription regulatory sequences derived from chlamydomonas reinhardtii | |
AU2001287631A1 (en) | Nucleotide sequences which code for the metf gene | |
AU2001278509A1 (en) | Nucleotide sequences which code for the atr43 gene | |
AU2001291658A1 (en) | Nucleotide sequences which code for the ccpa2 gene | |
AU2001293808A1 (en) | Nucleotide sequences which code for the atr61 gene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002735249 Country of ref document: EP Ref document number: 10684042 Country of ref document: US Ref document number: 2002581482 Country of ref document: JP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002735249 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |